Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quanterix (QTRX) Deferred Taxes (2022 - 2025)

Quanterix posted quarterly Deferred Taxes of -$189000.0 for Q4 2025, up 34.83% year-on-year from -$140179.0 in Q4 2024, and up 34.83% on a QoQ basis from -$290000.0 in Q4 2024.

Quanterix (QTRX) has 4 years of Deferred Taxes data on file, last reported at -$189000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Deferred Taxes rose 34.83% year-over-year to -$189000.0; the trailing twelve-month figure through Dec 2025 stood at -$1.1 million (down 30.82% YoY), and the FY2025 full-year result was -$5.9 million, down 1923.1% from the prior year.
  • Deferred Taxes for Q4 2025 stood at -$189000.0, up from -$290000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $270000.0 in Q1 2023 and bottomed at -$532000.0 in Q4 2023.
  • The 4-year median for Deferred Taxes is -$189000.0 (2025), against an average of -$147714.3.
  • The widest annual swing landed in 2023, when Deferred Taxes sank 100.75%; it then soared 45.49% in 2024.
  • A 4-year view of Deferred Taxes shows it stood at -$265000.0 in 2022, then tumbled by 100.75% to -$532000.0 in 2023, then jumped by 45.49% to -$290000.0 in 2024, then surged by 34.83% to -$189000.0 in 2025.
  • The last three Deferred Taxes figures came in at -$189000.0 (Q4 2025), -$290000.0 (Q4 2024), and -$532000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -33.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -101.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -351.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -9.40 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 300,000.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -16.70 Mn
10 Quanterix 165.84 Mn 66.57 Mn 15.57 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -189,000.00
Dec 31, 2024 -290,000.00
Dec 31, 2023 -532,000.00
Sep 30, 2023 -101,000.00
Jun 30, 2023 73,000.00
Mar 31, 2023 270,000.00
Dec 31, 2022 -265,000.00